tiprankstipranks
Advertisement
Advertisement

RLAY Stock Latest News

Relay Therapeutics price target raised to $21 from $17 at Barclays
The FlyRelay Therapeutics price target raised to $21 from $17 at Barclays
1d ago
RLAY
Relay Therapeutics price target raised to $19 from $14 at H.C. Wainwright
PremiumThe Fly
Relay Therapeutics price target raised to $19 from $14 at H.C. Wainwright
17d ago
RLAY
Relay Therapeutics: Encouraging Zovegalisib Phase 3 Prospects, Strong Cash Runway, and Raised Price Target Support Buy Rating
PremiumRatings
Relay Therapeutics: Encouraging Zovegalisib Phase 3 Prospects, Strong Cash Runway, and Raised Price Target Support Buy Rating
17d ago
RLAY
Relay Therapeutics price target raised to $17 from $15 at Citizens
PremiumThe Fly
Relay Therapeutics price target raised to $17 from $15 at Citizens
23d ago
RLAY
Relay Therapeutics Highlights Positive Zovegalisib ReDiscover Trial Data
PremiumCompany Announcements
Relay Therapeutics Highlights Positive Zovegalisib ReDiscover Trial Data
24d ago
8K
RLAY
Relay Therapeutics announces data from Phase 1/2 ReDiscover trial
PremiumThe FlyRelay Therapeutics announces data from Phase 1/2 ReDiscover trial
24d ago
RLAY
Relay Therapeutics price target raised to $22 from $15 at Guggenheim
Premium
The Fly
Relay Therapeutics price target raised to $22 from $15 at Guggenheim
27d ago
NVS
RLAY
Relay Therapeutics Updates Bylaws on Federal Securities Litigation
Premium
Company Announcements
Relay Therapeutics Updates Bylaws on Federal Securities Litigation
29d ago
8K
RLAY
Relay Therapeutics reports Q4 EPS (32c), consensus (39c)
PremiumThe Fly
Relay Therapeutics reports Q4 EPS (32c), consensus (39c)
1M ago
RLAY
RLAY Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RLAY Upcoming Earnings Report: What to Expect?
2M ago
RLAY
Relay Therapeutics Wins FDA Breakthrough Therapy Designation
PremiumCompany Announcements
Relay Therapeutics Wins FDA Breakthrough Therapy Designation
2M ago
8K
RLAY
Relay Therapeutics announces U.S. FDA granted BTD to zovegalisib
PremiumThe Fly
Relay Therapeutics announces U.S. FDA granted BTD to zovegalisib
2M ago
RLAY
Relay Therapeutics upgraded at Oppenheimer ahead of VIKTORIA-1 readout
PremiumThe FlyRelay Therapeutics upgraded at Oppenheimer ahead of VIKTORIA-1 readout
2M ago
RLAY
Relay Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Relay Therapeutics upgraded to Outperform from Perform at Oppenheimer
2M ago
RLAY
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
Premium
The Fly
Private Markets: SpaceX interviews banks to lead IPO, Skild AI raises $1.4B
3M ago
V
MA
Relay Therapeutics announces analysis of data for zovegalisib
PremiumThe Fly
Relay Therapeutics announces analysis of data for zovegalisib
4M ago
RLAY
Relay Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
Relay Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
4M ago
RLAY
Relay Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
PremiumRatings
Relay Therapeutics: Strong Financial Position and Promising Clinical Developments Justify Buy Rating
5M ago
RLAY
Relay Therapeutics Reports Q3 2025 Financial Progress
PremiumCompany Announcements
Relay Therapeutics Reports Q3 2025 Financial Progress
5M ago
RLAY
Relay Therapeutics reports Q3 EPS (43c), consensus (42c)
PremiumThe FlyRelay Therapeutics reports Q3 EPS (43c), consensus (42c)
5M ago
RLAY
Relay Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Relay Therapeutics Expands Board with New Appointments
5M ago
8K
RLAY
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
Premium
Company Announcements
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy
7M ago
RLAY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >